Why microbiome data is becoming essential in drug development

Studying the microbiome's interactions with drug products can yield new insights into safety, efficacy and more.

Saved in:
Bibliographic Details
Published inAustralasian biotechnology Vol. 33; no. 1; pp. 54 - 56
Main Author Kylie Ellis
Format Journal Article
Published Clayton, Vic Australian Biotechnology Association 01.04.2023
Subjects
Care
Drugs
Effectiveness
Patients
Safety measures
Therapeutic use
Online AccessGet full text

Cover

More Information
Summary:Studying the microbiome's interactions with drug products can yield new insights into safety, efficacy and more.
Bibliography:Australasian Biotechnology, Vol. 33, No. 1, Apr 2023, 54-56
Informit, Melbourne (Vic)
ISSN:1036-7128